EVA MARÍA
CIRUELOS GIL
Profesora asociada de Ciencias de la Salud
Centre Hospitalier Regional et Universitaire de Lille
Lila, FranciaPublications in collaboration with researchers from Centre Hospitalier Regional et Universitaire de Lille (1)
2015
-
Afatinib alone or afatinib plus vinorelbine versus investigator's choice of treatment for HER2-positive breast cancer with progressive brain metastases after trastuzumab, lapatinib, or both (LUX-Breast 3): A randomised, open-label, multicentre, phase 2 trial
The Lancet Oncology, Vol. 16, Núm. 16, pp. 1700-1710